journal article·2018-09

Effects of calcium and phosphorus incorporation on the properties and bioactivity of TiO 2 nanotubes

Paulo Soares, Marcela Ferreira Dias-Netipanyj, Selene Elifio-Esposito, Victoria Leszczak, Ketul Popat

Publisher page

Abstract

In this study, we investigate the formation of calcium and phosphorus-doped TiO 2 nanotubes, produced by potentiostatic anodization of Ti in viscous electrolyte-containing HF and Ca/P ions. Characterization of the produced oxide layer was conducted using scanning electron microscopy, glancing-angle X-ray diffraction, X-ray photoelectron spectroscopy, contact angle, and protein adsorption measurements. Adipose-derived stem cells were used to study material cytotoxicity, cell viability and proliferation, and cell morphology and growth. To evaluate the adipose-derived stem-cell differentiation, we investigated the expression of osteocalcin and osteopontin by cells as well as calcium mineralization. Results show that it was possible to produce a superhydrophilic titanium oxide nanotube layer with incorporation of Ca and P ions. The presence of Ca and P in the oxide layer not only improved the cell adhesion and proliferation but also stimulated the production of key marker proteins indicating differentiation of cells.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Calcium Carbonate Crystallization and Inhibition · 3D Printing in Biomedical Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Pontificia Universidade Catolica do Parana, Curitiba, Paraná, Brazil

Colorado State University, Fort Collins, Colorado, USA

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico · National Institute of Arthritis and Musculoskeletal and Skin Diseases

References (67)

Show source-provided references
1. 10.1016/S1350-4533(01)00050-910.1016/S1350-4533(01)00050-9 ↗
2. 10.1155/2016/290857010.1155/2016/2908570 ↗
3. 10.1021/acsbiomaterials.6b0060410.1021/acsbiomaterials.6b00604 ↗
4. Sul YT · Int J Oral Max Impl · 2005 · 20 · 349
5. 10.1016/j.msec.2016.03.04910.1016/j.msec.2016.03.049 ↗
6. 10.3390/ma1011130210.3390/ma10111302 ↗
7. 10.1002/term.410.1002/term.4 ↗
8. 10.1016/j.biomaterials.2003.11.01110.1016/j.biomaterials.2003.11.011 ↗
9. 10.1016/j.colsurfb.2006.03.01610.1016/j.colsurfb.2006.03.016 ↗
10. 10.1016/S0142-9612(03)00366-110.1016/S0142-9612(03)00366-1 ↗
11. 10.1016/j.biomaterials.2003.10.04410.1016/j.biomaterials.2003.10.044 ↗
12. Ding X · Int J Nanomedicine · 2015 · 10 · 6955
13. 10.1016/j.dental.2006.06.02510.1016/j.dental.2006.06.025 ↗
14. 10.1016/S0142-9612(00)00382-310.1016/S0142-9612(00)00382-3 ↗
15. 10.1177/15440591060850060310.1177/154405910608500603 ↗
16. 10.1016/j.biomaterials.2007.03.02010.1016/j.biomaterials.2007.03.020 ↗
17. 10.1002/jbm.a.3072210.1002/jbm.a.30722 ↗
18. Bjursten LM · J Biomed Mater Res · 2010 · 92 · 121810.1002/jbm.a.32463 ↗
19. 10.1016/j.actbio.2009.05.00810.1016/j.actbio.2009.05.008 ↗
20. 10.1016/j.bone.2004.03.00910.1016/j.bone.2004.03.009 ↗
21. 10.3390/ijms1401191810.3390/ijms14011918 ↗
22. 10.1002/jbm.b.3282310.1002/jbm.b.32823 ↗
23. 10.1002/(SICI)1096-9918(199907)27:7<629::AID-SIA551>3.0.CO;2-010.1002/(SICI)1096-9918(199907)27:7<629::AID-SIA551>3.0.CO;2-0 ↗
24. 10.1557/JMR.2001.045710.1557/JMR.2001.0457 ↗
25. 10.1002/anie.20100137410.1002/anie.201001374 ↗
26. 10.1016/j.cossms.2007.08.00410.1016/j.cossms.2007.08.004 ↗
27. 10.1016/S0142-9612(01)00317-910.1016/S0142-9612(01)00317-9 ↗
28. 10.1016/S0167-5729(00)00011-X10.1016/S0167-5729(00)00011-X ↗
29. 10.1016/0142-9612(91)90057-H10.1016/0142-9612(91)90057-H ↗
30. 10.1002/(SICI)1097-4636(199707)36:1<131::AID-JBM16>3.0.CO;2-L10.1002/(SICI)1097-4636(199707)36:1<131::AID-JBM16>3.0.CO;2-L ↗
31. 10.1155/2012/38153510.1155/2012/381535 ↗
32. 10.1098/rsfs.2012.001210.1098/rsfs.2012.0012 ↗
33. 10.1016/j.electacta.2007.07.06710.1016/j.electacta.2007.07.067 ↗
34. 10.1263/jbb.100.10010.1263/jbb.100.100 ↗
35. 10.1116/1.493257910.1116/1.4932579 ↗
36. 10.1016/S0142-9612(00)00394-X10.1016/S0142-9612(00)00394-X ↗
37. 10.1111/j.1708-8208.2004.tb00032.x10.1111/j.1708-8208.2004.tb00032.x ↗
38. 10.1016/j.msec.2014.01.00610.1016/j.msec.2014.01.006 ↗
39. 10.1111/j.1365-2842.2006.01669.x10.1111/j.1365-2842.2006.01669.x ↗
40. 10.1016/j.msec.2013.01.00210.1016/j.msec.2013.01.002 ↗
41. 10.1016/j.msec.2015.02.03610.1016/j.msec.2015.02.036 ↗
42. 10.1007/s40735-015-0024-x10.1007/s40735-015-0024-x ↗
43. 10.1039/C7RA08263K10.1039/C7RA08263K ↗
44. 10.1016/j.apsusc.2016.12.10510.1016/j.apsusc.2016.12.105 ↗
45. 10.1107/S002188981003049910.1107/S0021889810030499 ↗
46. 10.1016/j.actbio.2009.02.03210.1016/j.actbio.2009.02.032 ↗
47. 10.1016/j.actbio.2012.04.00510.1016/j.actbio.2012.04.005 ↗
48. 10.4491/eer.2015.06210.4491/eer.2015.062 ↗
49. 10.1246/cl.16077310.1246/cl.160773 ↗
50. Photharin S · Int J Appl Eng Res · 2017 · 12 · 1350
51. 10.1002/jbm.a.1041410.1002/jbm.a.10414 ↗
52. 10.1038/srep3176910.1038/srep31769 ↗
53. Moulder JF, Stickle WF, Sobol PE, et al. Handbook of X-ray photoelectron spectroscopy (Chastan J, ed). Eden Praire, USA: Perkin-Elmer Corporation, 1992.
54. 10.1007/s12540-009-0493-x10.1007/s12540-009-0493-x ↗
55. 10.1021/la001521310.1021/la0015213 ↗
56. 10.1016/0022-3093(90)90245-H10.1016/0022-3093(90)90245-H ↗
57. 10.1016/j.actbio.2012.12.00210.1016/j.actbio.2012.12.002 ↗
58. 10.1002/jbm.a.3285310.1002/jbm.a.32853 ↗
59. 10.1016/S0142-9612(98)00184-710.1016/S0142-9612(98)00184-7 ↗
60. 10.1002/masy.1996103010410.1002/masy.19961030104 ↗
61. Kohavi D · Clin Oral Impl Res · 2013 · 24 · 100210.1111/j.1600-0501.2012.02508.x ↗
62. 10.1093/humrep/dem01110.1093/humrep/dem011 ↗
63. 10.1046/j.1432-1327.2000.01606.x10.1046/j.1432-1327.2000.01606.x ↗
64. Robinson RA. · Johns Hopkins Med J · 1979 · 145 · 10
65. Toppets V · Vét · 2004 · 148 · 1
66. 10.1096/fasebj.4.13.221015710.1096/fasebj.4.13.2210157 ↗
67. Grafenau P · Vet Med · 2000 · 45 · 209